Citi remover Intuitive Surgical from the firm’s Focus List while keeping a Buy rating on the shares with a $462 price target. The firm also removed the stock’s “Top Pick designation” saying we have moved from robot anticipation to the da Vinci 5 launch. Management reiterated expectations for a limited launch through early 2025 as it works through supply chain challenges and enhanced features, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- 3 Best Non-Nvidia AI Stocks to Buy in May 2024, as per Analysts
- Intuitive Surgical Board Changes and Stockholder Votes
- Intuitive Announces Board of Directors Elections and Retirements
- Intuitive Surgical Stock (NYSE:ISRG): 2024 Kicks Off on a High Note
- Stryker added to ‘Tactical Outperform’ list at Evercore ISI
